Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I Scher

Showing results (461-470 of 692) with videos related to

Pageof 70
Sort By:
Nuclear Medicine and Biology|August 1, 1996
Detection of bony metastases of androgen-independent prostate cancer by PET-FDGS D Yeh, M Imbriaco, S M Larson, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 11, 2011
Practical approach for comparative analysis of multilesion molecular imaging using a semiautomated program for PET/CTJosef J Fox, Estelle Autran-Blanc, Michael J Morris, et al.
Seminars in Nuclear Medicine|January 1, 1992
Rhenium-186 hydroxyethylidene diphosphonate for the treatment of painful osseous metastasesH R Maxon, S R Thomas, V S Hertzberg, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 1, 1990
Adjunctive surgery after chemotherapy for nonseminomatous germ cell tumors: recommendations for patient selectionG C Toner, D M Panicek, R T Heelan, et al.
The American Journal of Surgical Pathology|November 26, 2010
Prostate cancer topography and patterns of lymph node metastasisYuji Tokuda, Lauren J Carlino, Anuradha Gopalan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 3, 2008
Circulating tumor cells predict survival benefit from treatment in metastatic castration-resistant prostate cancerJohann S de Bono, Howard I Scher, R Bruce Montgomery, et al.
Nature Medicine|July 3, 2013
ETS factors reprogram the androgen receptor cistrome and prime prostate tumorigenesis in response to PTEN lossYu Chen, Ping Chi, Shira Rockowitz, et al.
The Journal of Headache and Pain|January 29, 2014
The methodology of population surveys of headache prevalence, burden and cost: principles and recommendations from the Global Campaign against HeadacheLars Jacob Stovner, Mohammed Al Jumah, Gretchen L Birbeck, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 3, 2007
Phase I evaluation of J591 as a vascular targeting agent in progressive solid tumorsMichael J Morris, Neeta Pandit-Taskar, Chaitanya R Divgi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 10, 1999
Prognostic significance of extent of disease in bone in patients with androgen-independent prostate cancerP Sabbatini, S M Larson, A Kremer, et al.
Pageof 70

Showing results (461-470 of 692) with videos related to

Sort By:
Pageof 70
Nuclear Medicine and Biology|August 1, 1996
Detection of bony metastases of androgen-independent prostate cancer by PET-FDGS D Yeh, M Imbriaco, S M Larson, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 11, 2011
Practical approach for comparative analysis of multilesion molecular imaging using a semiautomated program for PET/CTJosef J Fox, Estelle Autran-Blanc, Michael J Morris, et al.
Seminars in Nuclear Medicine|January 1, 1992
Rhenium-186 hydroxyethylidene diphosphonate for the treatment of painful osseous metastasesH R Maxon, S R Thomas, V S Hertzberg, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 1, 1990
Adjunctive surgery after chemotherapy for nonseminomatous germ cell tumors: recommendations for patient selectionG C Toner, D M Panicek, R T Heelan, et al.
The American Journal of Surgical Pathology|November 26, 2010
Prostate cancer topography and patterns of lymph node metastasisYuji Tokuda, Lauren J Carlino, Anuradha Gopalan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 3, 2008
Circulating tumor cells predict survival benefit from treatment in metastatic castration-resistant prostate cancerJohann S de Bono, Howard I Scher, R Bruce Montgomery, et al.
Nature Medicine|July 3, 2013
ETS factors reprogram the androgen receptor cistrome and prime prostate tumorigenesis in response to PTEN lossYu Chen, Ping Chi, Shira Rockowitz, et al.
The Journal of Headache and Pain|January 29, 2014
The methodology of population surveys of headache prevalence, burden and cost: principles and recommendations from the Global Campaign against HeadacheLars Jacob Stovner, Mohammed Al Jumah, Gretchen L Birbeck, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 3, 2007
Phase I evaluation of J591 as a vascular targeting agent in progressive solid tumorsMichael J Morris, Neeta Pandit-Taskar, Chaitanya R Divgi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 10, 1999
Prognostic significance of extent of disease in bone in patients with androgen-independent prostate cancerP Sabbatini, S M Larson, A Kremer, et al.
Pageof 70